NASDAQ: ISRGIntuitive Surgical Inc Stock
$482.74+1.40 (+0.29%)
Updated Apr 17, 2025
ISRG Price
$482.74
Fair Value Price
$119.33
Market Cap
$172.17B
52 Week Low
$364.31
52 Week High
$616.00
P/E
73.81x
P/B
10.48x
P/S
22.2x
PEG
7.15x
Dividend Yield
N/A
Revenue
$8.35B
Earnings
$2.32B
Gross Margin
67.5%
Operating Margin
31.84%
Profit Margin
27.8%
Debt to Equity
0.14
Operating Cash Flow
$2B
Beta
1.31
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ISRG Overview
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ISRG's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical
Industry Rating
B
ISRG
Ranked#12 of 41
Ranked#12 of 41
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $4.91 | A | |
| $90.89 | B | |
| $60.83 | B |
Be the first to know about important ISRG news, forecast changes, insider trades & much more!
ISRG News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ISRG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ISRG ($482.74) is overvalued by 304.53% relative to our estimate of its Fair Value price of $119.33 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ISRG ($482.74) is not significantly undervalued (304.53%) relative to our estimate of its Fair Value price of $119.33 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ISRG ($482.74) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ISRG due diligence checks available for Premium users.
Valuation
ISRG fair value
Fair Value of ISRG stock based on Discounted Cash Flow (DCF)
Price
$482.74
Fair Value
$119.33
Overvalued by
304.53%
ISRG ($482.74) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ISRG ($482.74) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ISRG ($482.74) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ISRG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
73.81x
Industry
40.39x
Market
27.98x
ISRG is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ISRG is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
ISRG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
10.48x
Industry
3.55x
ISRG is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ISRG price to earnings growth (PEG)
For valuing profitable companies with growth potential
ISRG is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
ISRG's financial health
Profit margin
Revenue
$2.4B
Net Income
$685.7M
Profit Margin
28.4%
ISRG's Earnings (EBIT) of $2.66B... subscribe to Premium to read more.
Interest Coverage Financials
ISRG's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$18.7B
Liabilities
$2.2B
Debt to equity
0.14
ISRG's short-term assets ($7.11B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ISRG's short-term assets ($7.11B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ISRG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ISRG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$822.6M
Investing
-$1.3B
Financing
$49.4M
ISRG's operating cash flow ($2.42B)... subscribe to Premium to read more.
Debt Coverage Financials
ISRG vs Medical Stocks
Intuitive Surgical Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.